2003

• 25/02/2003

  ESMERTEC acquires Insignia JVM business assets and becomes master distributor of Insignia’s Java Virtual Machine solution e

• 20/03/2003

  Sofinnova Partners and Sofinnova Ventures Host Inaugural CEO Day Conference

• 17/04/2003

  Diatos expands its management team

• 28/04/2003

  Jean-Bernard Schmidt says Europe's post-bubble VCs now have the right focus: "Technology and funding seed startups" : interview for BusinessWeek

• 02/05/2003

  Ingenium publishes in Science groundbreaking results about the pathogenetic cause for motor neuron disease

• 14/05/2003

  Novuspharma SpA Announces Financial Results for the Three Months Ended 31 March 2003

• 05/06/2003

  Jean-Bernard Schmidt elected as Association Chairman in 20th year of EVCA

• 05/06/2003

  FT.com : "Challenge for Schmidt in private equity"

• 05/06/2003

  l'Agefi : Jean-Bernard Schmidt, un "venture capitalist" viscéral à la tête de l'association européenne du capital investissement

• 17/06/2003

  Cell Therapeutics, Inc. (CTI) Adds Pixantrone to its Oncology Drug Pipeline and Extends Global Cancer Business through Merger with Novuspharma S.p.a.

• 07/07/2003

  NovusPharma’s Pixantrone Regimen produces high response rates in relapsed aggressive lymphoma

• 28/07/2003

  Servista enables Lloyds TSB to launch home energy and telephone services

• 07/08/2003

  Novuspharma SpA Announces Financial Results for the Six Months Ended 30 June 2003

• 30/06/2003

  Q2 Another Record for AtomZ

• 02/09/2003

  Ingenium Appoints Dr. Klaus Dembowsky to Vice President Drug Discovery

• 10/09/2003

  Neuro3d raises M€ 10 from Existing Shareholders

• 30/09/2003

  Novuspharma Press Release: Financial Results for the nine months ended 30 September 2003

• 23/10/2003

  Cell Therapeutics, Inc. and Novuspharma S.p.A Announce Shareholder Approval of Merger

• 28/10/2003

  Cellzome Announces Research Collaboration with Johnson & Johnson R&D

• 13/11/2003

  Esmertec Nets €23m in Over-Subscribed Funding Round

• 25/11/2003

  IDM obtient un deuxième brevet au Japon

• 14/11/2003

  Innate Pharma and Novo Nordisk A/S sign licensing deal which opensnew avenue in cancer immunotherapy

• 19/11/2003

  Allergan et Exonhit initient leur premier criblage à haut flux sur une cible identifiée conjointement

• 19/11/2003

  Allergan and Exonhit designate target for high throughput screening

• 02/12/2003

  The pharmaceutical company Biolipox strengthens Board of Directors with a well known industrialist

• 10/12/2003

  Addex Pharmaceuticals SA Signs Three year Clinical Development Partnership with Fulcrum Pharma

• 12/12/2003

  Pixantrone Induces Impressive 77% Major Tumor Response Rate in Patients with Relapsed Aggressive Lymphoma when Substituted for Doxorubicin in CHOP Regimen

• 29/12/2003

  Happy New Year 2004 !

• 19/12/2003

  France Biotech Applauds the French Parliament’ Vote on the Status of the Young Innovative Company (YIC) in the 2004 Budget Bill

• 19/12/2003

  France Biotech se réjouit de l'adoption du statut de la jeune entreprise innovante dans la loi de finance 2004